AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2021
Nov 18, 2021
31721_dirs_2021-11-17_a1d2311c-cf73-4a2f-ba84-0c8ab734e08a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2021-11-16
Reporting Person: Mayo Stephen (Director)
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4